Rhythm Pharmaceuticals (RYTM)
NASDAQ:RYTM
Want to see RYTM full AI Analyst Report?
Rhythm Pharmaceuticals (RYTM) Ownership Overview
0.82% Insiders
31.22% Mutual Funds
50.73% Other Institutional Investors
15.32% ETFs
1.91% Public Companies and
Individual Investors
The ownership structure of Rhythm Pharmaceuticals (RYTM) stock is a mix of institutional, retail, and individual investors. Approximately 97.27% of the company’s stock is owned by Institutional Investors, 0.82% is owned by Insiders, and 1.91% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
May 19, 2026 | xxxxxxxxxxxxx | $428131 | |
Mar 06, 2026 | xxxxxxxxxxxxx | $502790 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2024 | xxxxxxxxxxxxx | $206448951 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $297220758 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $37966406 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $66000750 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,666,837 | Institution | 9.72% | 589,215,054 | |
| 5,870,184 | Institution | 8.56% | 518,806,862 | |
| 5,604,483 | Institution | 8.17% | 495,324,208 | |
| 5,309,646 | Institution | 7.74% | 469,266,513 | |
| 3,417,509 | Institution | 4.98% | 302,039,445 | |
| 3,277,081 | Institution | 4.78% | 289,628,419 | |
| 2,575,679 | Institution | 3.75% | 227,638,510 | |
| 2,373,795 | Institution | 3.46% | 209,796,002 | |
| 1,178,200 | Institution | 1.72% | 104,129,316 | |
| 1,156,062 | Institution | 1.69% | 102,172,760 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,309,646 | Institution | 7.74% | 469,266,513 | |
| 3,277,081 | Institution | 4.78% | 289,628,419 | |
| 1,178,200 | Institution | 1.72% | 104,129,316 | |
| 1,079,599 | Institution | 1.57% | 95,414,960 | |
| 852,562 | Institution | 1.24% | 75,349,430 | |
| 777,700 | Institution | 1.13% | 68,733,126 | |
| 676,232 | Institution | 0.99% | 59,765,384 | |
| 616,711 | Institution | 0.90% | 54,504,918 | |
| 560,299 | Institution | 0.82% | 49,519,226 | |
| 496,569 | Institution | 0.72% | 43,886,768 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,183,756 | Institution | 3.18% | 177,670,388 | |
| 1,573,510 | Institution | 2.29% | 128,020,774 | |
| 1,251,213 | Institution | 1.82% | 110,582,205 | |
| 1,063,534 | Institution | 1.55% | 93,995,135 | |
| 882,314 | Institution | 1.29% | 71,785,067 | |
| 684,869 | Institution | 1.00% | 55,720,942 | |
| 469,404 | Institution | 0.68% | 41,485,926 | |
| 435,221 | Institution | 0.63% | 38,464,832 | |
| 292,750 | Institution | 0.43% | 25,873,245 | |
| 267,572 | Institution | 0.39% | 21,769,658 |
FAQ
Who Owns Rhythm Pharmaceuticals (RYTM)?
According to the latest TipRanks data, approximately 50.73% of the company's stock is held by institutional investors, 0.82% is held by insiders, and 1.91% is held by retail investors.
What percentage of Rhythm Pharmaceuticals (RYTM) stock is held by institutional investors?
According to the latest TipRanks data, approximately 50.73% of Rhythm Pharmaceuticals (RYTM) stock is held by institutional investors.
What percentage of Rhythm Pharmaceuticals (RYTM) stock is held by retail investors?
According to the latest TipRanks data, approximately 1.91% of Rhythm Pharmaceuticals (RYTM) stock is held by retail investors.
Who owns the most shares of Rhythm Pharmaceuticals (RYTM)?
Peter Kolchinsky owns the most shares of Rhythm Pharmaceuticals (RYTM).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.